MR [Mindray Medical International] SC 13G: CUSIP No.: 602675100 1. Names of Reporting Persons:

[CUSIP No.: 602675100 1. Names of Reporting Persons: Manning & Napiervisors, I.R.S. Identification Nos. ofove persons (entities only): 45-3240790 2. Check the Appropriate Box if a Member of a (See Instructions): (a) 3. SEC Use Only: 4. Citizenship or Place of Organization: New York Numberof Shares Beneficially]

MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Medical Announces Preliminary 2011 Operating Results and Provides 2012 Net Revenue Guidance SHENZHEN, China, January 9, 2012 – Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced selected preliminary, unaudited results for the fiscal year ended December 31, 2011. The company also provided net revenue guidance for 2012. For the] [Mindray Medical Exceeds 2011 Product Development Targets and Announces Strong 2012 Pipeline SHENZHEN, China, Jan 9, 2012 /PRNewswire via COMTEX/ — Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced updates on new product launches for 2011 and its product pipeline for domestic and international markets in 2012. New product summary]

MR [Mindray Medical International] 6-K: Mindray Medical Announces Preliminary 2011 Operating Results and

[Mindray Medical Announces Preliminary 2011 Operating Results and Provides 2012 Net Revenue Guidance SHENZHEN, China, January 9, 2012 – Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced selected preliminary, unaudited results for the fiscal year ended December 31, 2011. The company also provided net revenue guidance for 2012. For the] [Mindray Medical Exceeds 2011 Product Development Targets and Announces Strong 2012 Pipeline SHENZHEN, China, Jan 9, 2012 /PRNewswire via COMTEX/ — Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced updates on new product launches for 2011 and its product pipeline for domestic and international markets in 2012. New product summary]

MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Medical Announces Preliminary 2011 Operating Results and Provides 2012 Net Revenue Guidance SHENZHEN, China, January9, 2012 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced selected preliminary, unaudited results for the fiscal year ended December31, 2011. Thempanyso provided net revenue guidance for 2012.] [Mindray Medical Exceeds 2011 Product Development Targets and Announces Strong 2012 Pipeline SHENZHEN, China, Jan 9, 2012 /PRNewswire viaMTEX/ Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced updates on new product launches for 2011 and its product pipeline for domestic and international markets in 2012.]

MR [Mindray Medical International] 6-K: Mindray Medical Announces Preliminary 2011 Operating Results and

[Mindray Medical Announces Preliminary 2011 Operating Results and Provides 2012 Net Revenue Guidance SHENZHEN, China, January9, 2012 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced selected preliminary, unaudited results for the fiscal year ended December31, 2011. Thempanyso provided net revenue guidance for 2012.] [Mindray Medical Exceeds 2011 Product Development Targets and Announces Strong 2012 Pipeline SHENZHEN, China, Jan 9, 2012 /PRNewswire viaMTEX/ Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced updates on new product launches for 2011 and its product pipeline for domestic and international markets in 2012.]

MR [Mindray Medical International] 6-K: Mindray Medical Announces Preliminary 2011 Operating Results and

[Mindray Medical Announces Preliminary 2011 Operating Results and Provides 2012 Net Revenue Guidance SHENZHEN, China, January9, 2012 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced selected preliminary, unaudited results for the fiscal year ended December31, 2011. Thempanyso provided net revenue guidance for 2012.] [Mindray Medical Exceeds 2011 Product Development Targets and Announces Strong 2012 Pipeline SHENZHEN, China, Jan 9, 2012 /PRNewswire viaMTEX/ Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced updates on new product launches for 2011 and its product pipeline for domestic and international markets in 2012.]

DHRM [Dehaier Medical Systems] 8-K: (Original Filing)

[Dehaier Medical Systems Limited NASDAQ : DHRM January, 2012 • Introduction • History • Management Company Overview • Product Categories and Market Business Overview • Financial Highlights Financial Results • Growth Strategy • New Business Initiatives Growth Plan About Us A leading China - based manufacturer and distributor of professional medical equipment as well as homecare medical products. » Founded] [FORM 8-K CURRENT REPORT Date of report (date of earliest event reported): January 6, 2012 DEHAIER MEDICAL SYSTEMS LIMITED British Virgin Islands 001-34661 N/A (State or Other Jurisdiction of Incorporation) (IRS Employer Identification No.) Suite 501, Jiuzhou Plaza 83 Fuxing Road, Haidian District Beijing 100856 China +86 (10) 5166-0080 Not Applicable (Former name or former address, if changed since last]

DHRM [Dehaier Medical Systems] 8-K: Dehaier Medical Systems Limited NASDAQ : DHRM January,

[Dehaier Medical Systems Limited NASDAQ : DHRM January, 2012 • Introduction • History • Management Company Overview • Product Categories and Market Business Overview • Financial Highlights Financial Results • Growth Strategy • New Business Initiatives Growth Plan About Us A leading China - based manufacturer and distributor of professional medical equipment as well as homecare medical products. » Founded] [FORM 8-K CURRENT REPORT Date of report (date of earliest event reported): January 6, 2012 DEHAIER MEDICAL SYSTEMS LIMITED British Virgin Islands 001-34661 N/A (State or Other Jurisdiction of Incorporation) (IRS Employer Identification No.) Suite 501, Jiuzhou Plaza 83 Fuxing Road, Haidian District Beijing 100856 China +86 (10) 5166-0080 Not Applicable (Former name or former address, if changed since last]

MR [Mindray Medical International] S-8: (Original Filing)

[] [MINDRAY MEDICAL INTERNATIONAL LIMITED SHARE INCENTIVE PLAN PREFACE This Plan is divided into two separate equity programs: (1) the option grant program set forth in Section 5 under which Eligible Persons (as defined in Section 3) may, at the discretion of the Administrator, be granted Options, and (2) the share award program set forth in Section 6 under which Eligible] [January 5, 2012 Mindray Medical International Limited Mindray Building Keji 12 th Road South Hi-tech Industrial Park Nanshen Shenzhen 518057 People’s Republic of China (852) 2842 9556 Christopher.Bickley@conyersdill.com Dear Sirs, Mindray Medical International Limited (the “Company”) Commission Registration Statement Securities Act Ordinary Shares Plan Resolutions Certificate Date For the purposes of giving this opinion, we have examined copies of the] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in this Registration Statement on Form S-8 of our report dated April 8, 2011 relating to the financial statements, financial statements schedules and the effectiveness of internal control over financial reporting, which appears in Mindray Medical International Limited’s Annual Report on Form 20-F for the]

MR [Mindray Medical International] S-8:

[] [MINDRAY MEDICAL INTERNATIONAL LIMITED SHARE INCENTIVE PLAN PREFACE This Plan is divided into two separate equity programs: (1) the option grant program set forth in Section 5 under which Eligible Persons (as defined in Section 3) may, at the discretion of the Administrator, be granted Options, and (2) the share award program set forth in Section 6 under which Eligible] [January 5, 2012 Mindray Medical International Limited Mindray Building Keji 12 th Road South Hi-tech Industrial Park Nanshen Shenzhen 518057 People’s Republic of China (852) 2842 9556 Christopher.Bickley@conyersdill.com Dear Sirs, Mindray Medical International Limited (the “Company”) Commission Registration Statement Securities Act Ordinary Shares Plan Resolutions Certificate Date For the purposes of giving this opinion, we have examined copies of the] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in this Registration Statement on Form S-8 of our report dated April 8, 2011 relating to the financial statements, financial statements schedules and the effectiveness of internal control over financial reporting, which appears in Mindray Medical International Limited’s Annual Report on Form 20-F for the]

Skip to toolbar